Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis

Biologic drugs, especially anti-TNF, are considered as the gold standard therapy in rheumatoid arthritis. However, non-uniform efficacy, incidence of infections, and high costs are major concerns. Novel tissue-specific agents may overcome the current limitations of systemic administration, providing...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Mathieu, Onuoha, Shimobi C., Fossati-Jimack, Liliane, Nerviani, Alessandra, Alves, Pedro L., Pagani, Sara, Deantonio, Cecilia, Colombo, Federico, Santoro, Claudio, Sblattero, Daniele, Pitzalis, Costantino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933454/
https://www.ncbi.nlm.nih.gov/pubmed/33679801
http://dx.doi.org/10.3389/fimmu.2021.640070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933454/
https://www.ncbi.nlm.nih.gov/pubmed/33679801
http://dx.doi.org/10.3389/fimmu.2021.640070

Ejemplares similares